1
|
Hussein MR, Haemel AK and Wood GS:
Apoptosis and melanoma: Molecular mechanisms. J Pathol.
199:275–288. 2003. View Article : Google Scholar : PubMed/NCBI
|
2
|
Soengas MS and Lowe SW: Apoptosis and
melanoma chemoresistance. Oncogene. 22:3138–3151. 2003. View Article : Google Scholar : PubMed/NCBI
|
3
|
Senderowicz AM: Novel small molecule
cyclin-dependent kinases modulators in human clinical trials.
Cancer Biol Ther. 2 4 Suppl 1:S84–S95. 2003. View Article : Google Scholar : PubMed/NCBI
|
4
|
Comis RL: DTIC (NSC-45388) in malignant
melanoma: A perspective. Cancer Treat Rep. 60:165–176.
1976.PubMed/NCBI
|
5
|
McClay EF and McClay ME: Tamoxifen: Is it
useful in the treatment of patients with metastatic melanoma? J
Clin Oncol. 12:617–626. 1994. View Article : Google Scholar : PubMed/NCBI
|
6
|
Cragg GM, Boyd MR, Cardellina JH, Grever
MR, Schepartz SA, Snader KM and Matthew S: Role of Plants in the
National cancer Institute drug discovery and development program.
ACS Symposium Series. 534:80–95. 2009.
|
7
|
Sehdev V, Lai JC and Bhushan A: Biochanin
A modulates cell viability, invasion, and growth promoting
signaling pathways in HER-2-positive breast cancer cells. J Oncol.
2009:1214582009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Seo YJ, Kim BS, Chun SY, Park YK, Kang KS
and Kwon TG: Apoptotic effects of genistein, biochanin-A and
apigenin on LNCaP and PC-3 cells by p21 through transcriptional
inhibition of polo-like kinase-1. J Korean Med Sci. 26:1489–1494.
2011. View Article : Google Scholar : PubMed/NCBI
|
9
|
Bhardwaj V, Tadinada SM, Jain A, Sehdev V,
Daniels CK, Lai JC and Bhushan A: Biochanin A reduces pancreatic
cancer survival and progression. Anticancer Drugs. 25:296–302.
2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Medjakovic S and Jungbauer A: Red clover
isoflavones Biochanin A and formononetin are potent ligands of the
human aryl hydrocarbon receptor. J Steroid Biochem Mol Biol.
108:171–177. 2008. View Article : Google Scholar : PubMed/NCBI
|
11
|
Hodek P, Trefil P and Stiborová M:
Flavonoids-Potent and versatile biologically active compounds
interacting with cytochromes P450. Chem Biol Interact. 139:1–21.
2002. View Article : Google Scholar : PubMed/NCBI
|
12
|
Manthey JA, Guthrie N and Grohmann K:
Biological properties of Citrus flavonoids Pertaining to cancer and
inflammation. Curr Med Chem. 8:135–153. 2001. View Article : Google Scholar : PubMed/NCBI
|
13
|
Surh YJ: Cancer chemoprevention with
dietary phytochemicals. Nat Rev Cancer. 3:768–780. 2003. View Article : Google Scholar : PubMed/NCBI
|
14
|
Galati G, Teng S, Moridani MY, Chan TS and
Brien OPJ: Cancer chemoprevention and apoptosis mechanisms induced
by dietary polyphenolics. Drug Metabol Drug Interact. 17:311–349.
2000. View Article : Google Scholar : PubMed/NCBI
|
15
|
Yang CS, Landau JM, Huang MT and Newmark
HL: Inhibition of carcinogenesis by dietary polyphenolic compounds.
Annu Rev Nutr. 21:381–406. 2001. View Article : Google Scholar : PubMed/NCBI
|
16
|
Banday JA, Shah SA, Kanth AH, Farozi A and
Wani H: In Vitro screening for anticancer activity of petroleum
ether and ethyl acetate extracts of Conyza canedensis growing in
Kashmir region. Adv Biomed Pharma. 2:82–85. 2015. View Article : Google Scholar
|
17
|
Park GB, Kim DJ, Kim YS, Lee HK, Kim CW
and Hur DY: Silencing of galectin-3 represses osteosarcoma cell
migration and invasion through inhibition of FAK/Src/Lyn activation
and β-catenin expression and increases susceptibility to
chemotherapeutic agents. Int J Oncol. 46:185–194. 2015. View Article : Google Scholar : PubMed/NCBI
|
18
|
Li X, Yang G, Li X, Zhang Y, Yang J, Chang
J, Sun X, Zhou X, Guo Y, Xu Y, et al: Traditional Chinese medicine
in cancer care: A review of controlled clinical studies published
in Chinese. PLoS One. 8:e603382013. View Article : Google Scholar : PubMed/NCBI
|